Platelet activating factor inhibition in sepsis: the end?
Rabinovici
Reuven
R
D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase; D023381:Endpoint Determination; D006801:Humans; D010741:Phospholipases A / Q000494:pharmacology / Q000627:therapeutic use*; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors* / Q000276:immunology; D012107:Research Design; D012128:Respiratory Distress Syndrome / Q000453:epidemiology / Q000517:prevention & control*; D018805:Sepsis / Q000188:drug therapy* / Q000401:mortality
D010972:Platelet Activating Factor; D010741:Phospholipases A; D043203:1-Alkyl-2-acetylglycerophosphocholine Esterase